These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 17156146
1. DLG5 R30Q variant is a female-specific protective factor in pediatric onset Crohn's disease. Biank V, Friedrichs F, Babusukumar U, Wang T, Stoll M, Broeckel U, Kugathasan S. Am J Gastroenterol; 2007 Feb; 102(2):391-8. PubMed ID: 17156146 [Abstract] [Full Text] [Related]
2. DLG5 variants in inflammatory bowel disease. Büning C, Geerdts L, Fiedler T, Gentz E, Pitre G, Reuter W, Luck W, Buhner S, Molnar T, Nagy F, Lonovics J, Dignass A, Landt O, Nickel R, Genschel J, Lochs H, Schmidt HH, Witt H. Am J Gastroenterol; 2006 Apr; 101(4):786-92. PubMed ID: 16494592 [Abstract] [Full Text] [Related]
5. Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. Babusukumar U, Wang T, McGuire E, Broeckel U, Kugathasan S. Am J Gastroenterol; 2006 Jun; 101(6):1354-61. PubMed ID: 16771961 [Abstract] [Full Text] [Related]
6. The contribution of the DLG5 113A variant in early-onset inflammatory bowel disease. Russell RK, Drummond HE, Nimmo ER, Anderson N, Wilson DC, Gillett PM, McGrogan P, Hassan K, Weaver LT, Bisset WM, Mahdi G, Satsangi J. J Pediatr; 2007 Mar; 150(3):268-73. PubMed ID: 17307543 [Abstract] [Full Text] [Related]
7. Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations. Medici V, Mascheretti S, Croucher PJ, Stoll M, Hampe J, Grebe J, Sturniolo GC, Solberg C, Jahnsen J, Moum B, Schreiber S, Vatn MH. Eur J Hum Genet; 2006 Apr; 14(4):459-68. PubMed ID: 16493449 [Abstract] [Full Text] [Related]
8. Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British population. Pearce AV, Fisher SA, Prescott NJ, Onnie CM, Pattni R, Green P, Forbes A, Mansfield J, Sanderson J, Schreiber S, Lewis CM, Mathew CG. Int J Colorectal Dis; 2007 Apr; 22(4):419-24. PubMed ID: 16944184 [Abstract] [Full Text] [Related]
10. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease. Török HP, Glas J, Endres I, Tonenchi L, Teshome MY, Wetzke M, Klein W, Lohse P, Ochsenkühn T, Folwaczny M, Göke B, Folwaczny C, Müller-Myhsok B, Brand S. Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129 [Abstract] [Full Text] [Related]
14. DLG5 R30Q is not associated with IBD in Hungarian IBD patients but predicts clinical response to steroids in Crohn's disease. Lakatos PL, Fischer S, Claes K, Kovacs A, Molnar T, Altorjay I, Demeter P, Tulassay Z, Palatka K, Papp M, Rutgeerts P, Szalay F, Papp J, Vermeire S, Lakatos L, Hungarian IBD Study Group. Inflamm Bowel Dis; 2006 May; 12(5):362-8. PubMed ID: 16670524 [Abstract] [Full Text] [Related]
15. Contribution of IBD5 locus to clinical features of IBD patients. Latiano A, Palmieri O, Valvano RM, D'Incà R, Vecchi M, Ferraris A, Sturniolo GC, Spina L, Lombardi G, Dallapiccola B, Andriulli A, Devoto M, Annese V. Am J Gastroenterol; 2006 Feb; 101(2):318-25. PubMed ID: 16454837 [Abstract] [Full Text] [Related]
16. Characterization of genotype-phenotype relationships and stratification by the CARD15 variant genotype for inflammatory bowel disease susceptibility loci using multiple short tandem repeat genetic markers. Crawford NP, Colliver DW, Funke AA, Young MN, Kelley S, Cobbs GA, Petras RE, Galandiuk S. Hum Mutat; 2005 Feb; 25(2):156-66. PubMed ID: 15643611 [Abstract] [Full Text] [Related]
17. The R30Q DLG5 variant is not associated with celiac disease or inflammatory bowel disease in the Spanish population. Dema B, Fernández-Arquero M, Maluenda C, Polanco I, Figueredo MA, De La Concha EG, Urcelay E, Núñez C. Tissue Antigens; 2011 Jan; 77(1):62-4. PubMed ID: 20796250 [Abstract] [Full Text] [Related]
18. Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins? Lakatos PL, Altorjay I, Mándi Y, Lakatos L, Tumpek J, Kovacs A, Molnar T, Tulassay Z, Miheller P, Palatka K, Szamosi T, Fischer S, Papp J, Hungarian IBD Study Group, Papp M. Tissue Antigens; 2008 Jun; 71(6):552-9. PubMed ID: 18397186 [Abstract] [Full Text] [Related]
20. DLG5 P1371Q is associated with inflammatory bowel disease and complementary to R30Q in disease susceptibility. Lin Z, Hegarty JP, Berb A, Wang Z, Kelly AA, Wang Y, Poritz LS, Wu R, Koltun WA. Swiss Med Wkly; 2011 Jun; 141():w13290. PubMed ID: 22065243 [Abstract] [Full Text] [Related] Page: [Next] [New Search]